Condition (MeSH)
Vitreous Detachment
ClinicalTrials.gov lists 23 trials for Vitreous Detachment or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Vitreous Detachment itself; the rest are tagged with a narrower condition beneath it.
When did Vitreous Detachment trials start? (15)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2023 | 1 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 1 |
| 2017 | 1 |
| 2015 | 3 |
| 2014 | 3 |
| 2013 | 1 |
Showing 10 of 15 earlier years.
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Vitreous Detachment trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 1 |
| Not applicable | 10 |
| Observational | 9 |
How many Vitreous Detachment trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 12 |
| Terminated | 3 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Vitreous Detachment trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Bausch & Lomb Incorporated | 1 |
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
| ThromboGenics | 1 |
Which drugs are being tested for Vitreous Detachment? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| rHuPH20 | 1 |
| Ocriplasmin | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Cataract surgery | 2 |
| Tissue Plasminogen Activator,bevacizumab ,follow up | 1 |
| 1% Sevoflurane | 1 |
| Intravenous Sedatives with or Without Analgesia | 1 |
| Oral Sedatives with or Without Analgesia | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Vitreous Detachment trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac Failure | 2 | 1 |
| Abdominal Wall Abscess | 1 | 1 |
| Acute Respiratory Failure | 1 | 1 |
| Adenocarcinoma of Colon | 1 | 1 |
| Anaemia | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Vitreous Detachment? (33)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration. | The British journal of ophthalmology | 2020 | Yes |
| Ocular complications and prophylactic strategies in Stickler syndrome: a systematic literature review. | Ophthalmic genetics | 2020 | Yes |
| Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study. | Ophthalmology. Retina | 2019 | Yes |
| Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature. | Acta ophthalmologica | 2018 | Yes |
| The vitreopapillary interface in healthy and glaucoma: posterior vitreous detachment in the vitreopapillary interface study. | Acta ophthalmologica | 2018 | Yes |
Showing 5 of 33 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.